Pediatrics Doctors in Boonville, IN Accepting Medicare

2 Pediatrics doctors found. Showing 1 - 2

Leslie A Keys, DT Pediatrics - Developmental – Behavioral Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1213 Tower Dr, Boonville, IN 47601 Phone: 812-449-5652

Gwendolyn Shelton, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1116 Millis Ave, Boonville, IN 47601 Phone: 812-897-7404

News Archive

Australia's largest skin cancer study

More than 400,000 people will be diagnosed with some form of skin cancer this year and the most deadly form of the disease, melanoma, will claim more than a thousand lives in Australia say researchers. Queensland has the highest rate of skin cancer in the world with fair-skinned people being most affected with the strong subtropical sun.

Penn researchers to present clinical data at 2015 ASCO Annual Meeting

Researchers from the Abramson Cancer Center of the University of Pennsylvania and Penn's Perelman School of Medicine will present results from several clinical trials and other key studies during the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 through June 2.

Watson Pharmaceuticals receives FDA approval for generic Accuneb

Watson Pharmaceuticals, Inc. has announced that it has received final approval from the United States (U.S.) Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for albuterol sulfate inhalation solution in the 0.021% (base) and 0.042% (base) strengths.

Hay fever vaccine shows efficacy in phase IIa trial

A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The vaccine BM32 is based on an innovative recombinant peptide carrier technology that allows for fewer injections and shows fewer side effects compared with other immunotherapy treatments for allergy sufferers. BM32 has been developed by Biomay AG, an Austrian biopharmaceutical company specialized in the discovery and development of innovative allergy therapeutics. The company has already initiated a Phase IIb trial for BM32 with 180 allergic patients.

Read more Medical News

› Verified 3 days ago